| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
The AS-30D rat hepatoma cell line is characteristic of that class of rapidly growing tumors which exhibit high rates of aerobic glucose utilization and lactic acid production (Bustamante, E., Morris, H. P., and Pedersen, P. L., J. Biol. Chem., 256: 86998704, 1981). In this study, we have examined the coupling properties of the mitochondria in intact AS-30D hepatoma cells and the relative contributions of cytoplasmic (glycolytic) and mitochondrial compartments to total cellular ATP production in the presence of glucose and glutamine. All respiration in AS-30D cells was inhibited by inhibitors of mitochondrial electron transport, ruling out significant rates of respiration from other cellular components. Moreover, cellular respiration was found to be coupled to phosphorylation of ADP, as demonstrated by its inhibition by oligomycin and aurovertin, inhibitors of the mitochondrial ATP synthetase (F0F1-ATPase). When intact cells were supplied with glucose as the only added energy source, it was estimated that about 60% of the total cell ATP was derived from glycolysis and 40% from oxidative phosphorylation. Addition of physiological concentrations of glutamine in the presence of glucose had little effect on the relative contributions of glycolysis and oxidative phosphorylation to total cellular ATP production. In the absence of added glucose, glutamine alone could maintain the same ATP production rates by supporting mitochondrial oxidative phosphorylation. It is concluded that, in the AS-30D hepatoma cell line, glucose is the preferred energy source, with the larger portion of ATP production being supplied by glycolytic reactions. Although oxidative substrates such as glutamine can replace glucose in maintaining total cell ATP production, they do not appear to be the major fuel sources when hepatoma AS-30D cells are exposed to concentrations of substrates which occur in vivo.
1 Supported by Grant CA 32742 from the National Cancer Institute, NIH.
2 Supported by NIH National Research Service Award 1 F32 CA 07506-01 from the National Cancer Institute.
3 Permanent address: Istituto Regina Elena per lo Studio e la Cura dei Tumori, V. le Regina Elena 291, 00161 Rome, Italy. Fellow of the Consiglio Nazionale delle Ricerche, sponsored by the Associazione Italiana per la Ricerca sul Cancro.
4 To whom requests for reprints should be addressed.
Received 4/24/84. Accepted 8/20/84.
This article has been cited by other articles:
![]() |
M. Fanciulli, T. Bruno, A. Giovannelli, F. P. Gentile, M. Di Padova, O. Rubiu, and A. Floridi Energy Metabolism of Human LoVo Colon Carcinoma Cells: Correlation to Drug Resistance and Influence of Lonidamine Clin. Cancer Res., April 1, 2000; 6(4): 1590 - 1597. [Abstract] [Full Text] |
||||
![]() |
M. Lopez de Heredia, J. M. Izquierdo, and J. M. Cuezva A Conserved Mechanism for Controlling the Translation of beta -F1-ATPase mRNA between the Fetal Liver and Cancer Cells J. Biol. Chem., March 15, 2000; 275(10): 7430 - 7437. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Campbell and P. Thorsness Escape of mitochondrial DNA to the nucleus in yme1 yeast is mediated by vacuolar-dependent turnover of abnormal mitochondrial compartments J. Cell Sci., January 8, 1998; 111(16): 2455 - 2464. [Abstract] [PDF] |
||||
![]() |
S. P. Mathupala, C. Heese, and P. L. Pedersen Glucose Catabolism in Cancer Cells. THE TYPE II HEXOKINASE PROMOTER CONTAINS FUNCTIONALLY ACTIVE RESPONSE ELEMENTS FOR THE TUMOR SUPPRESSOR p53 J. Biol. Chem., September 5, 1997; 272(36): 22776 - 22780. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sprecher, H. M. Barr, J. I. Slotky, M. Tzukerman, G. D. Eytan, and Y. G. Assaraf Alteration of Mitochondrial Gene Expression and Disruption of Respiratory Function by the Lipophilic Antifolate Pyrimethamine in Mammalian Cells J. Biol. Chem., September 1, 1995; 270(35): 20668 - 20676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Mathupala, A. Rempel, and P. L. Pedersen Glucose Catabolism in Cancer Cells J. Biol. Chem., July 14, 1995; 270(28): 16918 - 16925. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |